Showing results (351-360 of 388) with videos related to

Sort By:
Pageof 39
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 7, 2016
A Validated Prognostic Multigene Expression Assay for Overall Survival in Resected Colorectal Cancer Liver MetastasesVinod P Balachandran, Arshi Arora, Mithat Gönen, et al.
The Journal of Experimental Medicine|December 11, 2013
KIT oncogene inhibition drives intratumoral macrophage M2 polarizationMichael J Cavnar, Shan Zeng, Teresa S Kim, et al.
Lancet (London, England)|March 24, 2009
Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trialRonald P Dematteo, Karla V Ballman, Cristina R Antonescu, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|October 12, 2019
Lending a hand for laparoscopic distal pancreatectomy: the optimal approach?Adriana C Gamboa, Victoria G Aveson, Mohammad Y Zaidi, et al.
Nature Medicine|August 30, 2011
Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of IdoVinod P Balachandran, Michael J Cavnar, Shan Zeng, et al.
Cancer Immunology Research|February 23, 2018
Macrophages and CD8+ T Cells Mediate the Antitumor Efficacy of Combined CD40 Ligation and Imatinib Therapy in Gastrointestinal Stromal TumorsJennifer Q Zhang, Shan Zeng, Gerardo A Vitiello, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 4, 2014
Increased KIT inhibition enhances therapeutic efficacy in gastrointestinal stromal tumorTeresa S Kim, Michael J Cavnar, Noah A Cohen, et al.
Cancer|April 17, 2014
Risk factors for gastrointestinal stromal tumor recurrence in patients treated with adjuvant imatinibHeikki Joensuu, Mikael Eriksson, Kirsten Sundby Hall, et al.
Investigational New Drugs|August 14, 2018
A phase Ib study of BGJ398, a pan-FGFR kinase inhibitor in combination with imatinib in patients with advanced gastrointestinal stromal tumorCiara M Kelly, Alexander N Shoushtari, Li-Xuan Qin, et al.
Molecular Cancer Therapeutics|June 15, 2017
Wnt/β-catenin Signaling Contributes to Tumor Malignancy and Is Targetable in Gastrointestinal Stromal TumorShan Zeng, Adrian M Seifert, Jennifer Q Zhang, et al.
Pageof 39